D'Anjou, Helene,Ferrari, Nicolay,Paquet, Luc,DAnjou, Helene
申请号：
AU2009246000
公开号：
AU2009246000B2
申请日:
2009.03.31
申请国别(地区):
AU
年份:
2014
代理人:
摘要：
There is provided oligonucleotides directed against the CCR3 receptor and the common beta sub-unit of IL-3, IL-5 and GM-CSF receptors. The oligonucleotides are useful to inhibit general inflammation, including inflammation associated with asthma, COPD, allergy, Cystic fibrosis (CF), hypereosinophilia and neoplastic cell proliferation such as cancer.
